SEC Filing Details

Our enduring purpose: To fundamentally improve the lives of patients with serious diseases in ways never before possible

SEC Filing Details

Document Details

Form
Filing Date
Jun 12, 2019
Document Date
May 10, 2017
Form Description
An amendment to a 3 filing. Non-EDGAR filing
Filing Group
3,4,5
Company
Five Prime Therapeutics
Issuer
FIVE PRIME THERAPEUTICS, INC.
Filer
Nicholson Garry A